FDA ‘ups’ safety warnings for blood clots on birth control pill labels

According to federal health regulators more information needs to be added to labels on a popular class of birth control pills that includes Bayer AG's Yaz and Yasmin, to show they may raise the risk of blood clots. A clot in blood vessels can prove fatal if it breaks loose and travels to the lungs, heart or brain.

It is known that all birth control pills increase a woman's chances of getting potentially fatal blood clots. But the U.S. Food and Drug Administration (FDA) said on Tuesday that some studies showed the danger may be even higher for more recent pills that contain the compound drospirenone, a synthetic hormone.

“The revised drug labels will report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products ... whereas other epidemiological studies found no additional risk,” the FDA said in a statement. The FDA's own study found that 10 in 10,000 women taking pills with drospirenone would get a blood clot per year, compared with about six in 10,000 women taking older contraceptives. To put the risk into perspective however, the FDA added that the risk of blood clots from pregnancy is even higher than any risk from birth control pills.

The announcement comes after an advisory committee of outside experts to the FDA voted in December for a label revision for pills with drospirenone, calling for clearer information about their risks and benefits. The experts agreed that these pills' benefits outweighed their risks, since some studies found the pills did not increase blood clot risks.

During the December panel meeting, some women's advocacy groups called for the pills to be taken off the market, as the studies that viewed pills favorably were industry-funded. In January, the Project on Government Oversight urged the FDA to hold a new vote about the birth control pills after a study showed four of the FDA's advisers had ties in the past to makers of pills containing drospirenone. The FDA said past ties to industry are usually not considered conflicts under the law.

Cynthia Pearson, executive director of the National Women's Health Network, who testified at the December meeting, said that a simple label change would not necessarily protect women from blood clots. “I fear that if the FDA holds another public hearing three years from now, there will be a new group of women telling sad stories about the harm done to their health by clots,” she said on Tuesday.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). FDA ‘ups’ safety warnings for blood clots on birth control pill labels. News-Medical. Retrieved on November 29, 2024 from https://www.news-medical.net/news/20120411/FDA-ups-safety-warnings-for-blood-clots-on-birth-control-pill-labels.aspx.

  • MLA

    Mandal, Ananya. "FDA ‘ups’ safety warnings for blood clots on birth control pill labels". News-Medical. 29 November 2024. <https://www.news-medical.net/news/20120411/FDA-ups-safety-warnings-for-blood-clots-on-birth-control-pill-labels.aspx>.

  • Chicago

    Mandal, Ananya. "FDA ‘ups’ safety warnings for blood clots on birth control pill labels". News-Medical. https://www.news-medical.net/news/20120411/FDA-ups-safety-warnings-for-blood-clots-on-birth-control-pill-labels.aspx. (accessed November 29, 2024).

  • Harvard

    Mandal, Ananya. 2020. FDA ‘ups’ safety warnings for blood clots on birth control pill labels. News-Medical, viewed 29 November 2024, https://www.news-medical.net/news/20120411/FDA-ups-safety-warnings-for-blood-clots-on-birth-control-pill-labels.aspx.

Comments

  1. K K Australia says:

    About time! I was on Yasmin birth control pills for less than three months and developed blood clots in my left leg which broke into my lungs and if I hadn't gone to emergency I might have had a pulmonary embolism (a stroke) The risk of blood clots was not really explained that well to me when I started using Yasmin and some Doctors just brush off the risk of clots like it's impossible, trust me..it's really not.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Beer consumption alters red blood cell lipid composition